Article
Elevated plasma levels of CXCL16 in severe COVID-19 patients
2021-09-12
Abstract excerpt
Genome-wide association studies have recently identified 3p21.31, with lead variant pointing to the CXCR6 gene, as the strongest thus far reported susceptibility risk locus for severe manifestation of COVID-19. In order the determine its role, we measured plasma levels of Chemokine (C□X□C motif) ligand 16 (CXCL16) in the plasma of COVID-19 hospitalized patients. CXCL16 interacts with CXCR6 promoting chemotaxis or...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b3c3f51-b4a1-5dcb-8b1e-0ab028c09cde
- DOI
- 10.1101/2021.09.07.21263222
